4/A//SEC Filing
BRADLEY PHARMACEUTICALS INC 4/A
Accession 0000864268-04-000076
CIK 0000864268operating
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 10:36 AM ET
Size
15.7 KB
Accession
0000864268-04-000076
Insider Transaction Report
Form 4/AAmended
GLASSMAN IRIS
DirectorTreasurer
Transactions
- Discretionary Transaction
Stock Options (Right to buy)
2003-11-11$26.68/sh+1,667$44,476→ 5,000 totalExercise: $26.68From: 2006-11-11Exp: 2013-11-10→ Common Stock (1,667 underlying)
Holdings
- 18,000
Stock Options (Right to buy)
Exercise: $1.31From: 1998-09-12Exp: 2005-09-11→ Common Stock (18,000 underlying) - 4,000(indirect: By IRA)
Common Stock
- 15,200(indirect: By Trust)
Common Stock
- 16,403
Class B Common Stock
- 5,500(indirect: By Trust)
Common Stock
- 6,400(indirect: By Trust)
Common Stock
- 30,000
Stock Options (Right to buy)
Exercise: $7.76From: 2004-07-09Exp: 2006-07-08→ Common Stock (30,000 underlying) - 39,692
Common Stock
- 22,878
Stock Options (Right to buy)
Exercise: $1.06From: 1995-12-05Exp: 2005-12-04→ Common Stock (22,878 underlying) - 50,000
Stock Options (Right to buy)
Exercise: $1.31From: 1997-04-12Exp: 2004-04-11→ Common Stock (50,000 underlying)
Documents
Issuer
BRADLEY PHARMACEUTICALS INC
CIK 0000864268
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000864268
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 10:36 AM ET
- Size
- 15.7 KB